Introduction
Dopamine (DA) is an important neurotransmitter that is closely involved in the regulation of motor activities, higher cortical and neuroendocrine functions. 1, 2 Whereas functional aberrations of the central DA system have been implicated in psychoses including schizophrenia, the neurobiological basis of the disease remains elusive. 3, 4 This has been attributed, in part, to the complex actions of DA mediated through various receptor subtypes that may interact to produce intricate outcomes. [5] [6] [7] Unlike many neurotransmitters, DA is capable of exerting both stimulatory and inhibitory effects depending on receptor subtype involvement. [8] [9] [10] Thus, in the case of D 1 -like receptors, which include the D 1 -and D 5 -receptor subtypes, the amine acts as a stimulator in many biological systems while exerting 4 -receptor subtypes. Increasing evidence now suggests that subtypes of the DA receptor are differentially expressed in various regions of the brain. [11] [12] [13] Whereas D 1 receptors are found abundantly in basal ganglia, D 5 receptors are primarily present in the hypothalamus and cortices. [14] [15] [16] [17] More than one subtype of DA receptor can be expressed constitutively in the same cells. To date, up to three subtypes, namely D 1 , D 5 and D 2 receptors have been localized in neurons of the basal ganglian. 12 The phenotype of the relevant cells remains unclear, however. The functional significance of this observation is still to be fully appreciated. More interestingly, studies of the Chinese Hamster Ovary (CHO) cell line concurrently expressing D 1 and D 2 receptors have demonstrated that an antagonistic effect on cAMP production is detected when the two receptors are activated at the same time by dopamine. 18 However, the neurobiological relevance of this to the central nervous system is not certain.
Previously we have localized individually D 1 , D 5 or D 2 receptors in atrial natriuretic factor (ANF)-produc-ing neurons of the rat hypothalamus. [19] [20] [21] The neurons are stimulated or inhibited by D 1 -like and D 2 -like receptor activation respectively, through the modulation of the cAMP-dependent kinase A pathway. Using the same primary hypothalamic cell culture system, [22] [23] [24] we have now examined the effects of a concurrent activation of D 1 -like and D 2 -like receptors by DA, and by their respective agonists. The same studies have also been extended to include those performed in transfected CHO cells stably expressing D 5 and D 2 receptors.
Materials and methods

Cell cultures
Neonatal rat hypothalamic cultures were prepared 22, 25, 26 by enzymatic dispersion of hypothalami removed from 2 to 3-day-old Sprague-Dawley rat pups. The dispersed cells were maintained in Hepes buffered Dulbecco's Modified Eagle's Medium (HDME) supplemented with 8% fetal calf serum at 37°C in 10% CO 2 . All release studies were conducted on the 7th day of culture and extended over a period of 4 days. The drugs were applied every 24 h to the cultures. Four hours after the last application of vehicle or drugs, conditioned media were removed and extracted for immunoreactive (ir) ANF release measurement by double antibody RIA. [27] [28] [29] To determine the intracellular cAMP, the cultures medium was replenished with fresh culture medium containing IBMX for 30 min at 37°C after 4-day treatment with various drugs. The cells were then incubated with the same drugs for another 15 min. The reaction was terminated by aspirating the medium, adding 1 ml of stop solution (0.01 M of HCl in ethanol) and placing at room temperature (25°C) for 30 min. The extracts were lyophilized and reconstituted for cAMP radioimmunoassay. 20 Intracellular cyclic AMP was then extracted and quantified using RIA modified from the method described by Marley. 30 Each of the experiments was performed at least three times; within an experiment, the results of an individual condition represented the average of three to four cultured wells. Results presented here are the mean of three or more separate experiments from different batches of cell preparations.
Northern blot analysis
Following treatment, cells were lysed directly in the well by adding 0.5 ml of TRIZOL Reagent (Life Technologies, Grand Island, NY, USA). The cell lysate from three individual wells, each with 10 6 cells, was harvested by pipetting and pooled together as a single sample for the study. The cytoplasmic RNA was further extracted by chloroform and precipitated with isopropyl alcohol. Twelve micrograms of total RNA from each of the samples fractionated by electrophoresis through formaldehyde-agarose gel were transferred to nylon membrane and hybridized with digoxigenin-labeled ANF-antisense oligonucleotide probes [31] [32] [33] and visualized by colorimetric reaction. The signals of individual bands for pro-ANF mRNA were measured as integrated intensities by a computer based Image-Pro Plus version 3 (Media Cybernetics, MD, USA) taking the vehicle-treated controls as 100% for statistical comparison. After signal analysis, the same blots were reprobed with digoxigenin-labeled GAPDH mRNA oligonucleotide. The intensity readings of each band of pro-mRNA from various treatment groups were adjusted to that of corresponding bands of GAPDH mRNA; the values were then expressed as a percentage of that of the vehicle-treated controls.
Triple staining
Cells treated with vehicle were washed and fixed with 3% phosphate-buffered paraformaldehyde. 23, 33 After prehybridization, the cells were incubated overnight at 37°C with antisense oligonucleotide probes (200 pmol ml The specificity of the ir-ANF staining was demonstrated by the absence of specific staining when the primary antiserum was replaced with Tris buffer, normal rabbit serum, or anti-ANF antiserum preabsorbed with an excess amount of synthetic rat ANF (99-126). To eliminate the possibility of false positive staining in the in situ hybridization, the replacement of antisense probe with sense probe, pretreatment of fixed cultures with RNAase, coincubation with an excess of unlabeled oligo probes, application of anti-digoxigenin antiserum or FITC-conjugated strepABC complex without probe was carried out. For triple staining, negative controls which employed either primary antiserum or oligonucleotide probe alone in the presence of one of the non-corresponding second antisera were included. In all cases, no significant staining was observed above background. 34 To construct a PAXD 5 plasmid, total RNA was extracted from cultured rat hypothalamus by TRIZOL and amplified by RT-PCR. Primers corresponding to 5Ј-(TTCTCGAGCTACTCAGCGCGAC ATGC, 672-697, XhoI site underlined) and 3Ј-(TTCTATGCAGCAGACTACAGAAAGC, 2240-2264) untranslated regions of rat D 5 receptor cDNA were used in the PCR to amplify the full-length cDNA encoding the rat D 5 receptor. Hot start PCR were initiated as described before, 21 followed by 35 cycles of 95°C for 1 min, 62°C for 1 min and 72°C for 1 min, with a final extension at 72°C for 7 min. The PCR products were purified using the QIAquick Spin purification kit from Bresatec and the nucleotide sequence was confirmed by dideoxy sequencing of double strand DNA using the DNA sequencing system from Promega following manufacturer's instructions. Briefly, the samples were analyzed by electrophoresis on a 6% polyacrylamide, 7 M urea gel, dried onto Whatman 3 M paper, and exposed to X-ray film (Kodak BioMax, MR-1, Kodak) for 16 h at −70°C. The sequence of the amplified cDNA was identical to the published rat D 5 receptor sequence. The cDNA was then modified by adding a HindIII linker at 3Ј end and cloned into the SalI and HindIII sites of PAX. 34 CHO cells were grown in ␣-medium (Gibco RBI) supplemented with 8% FCS in six well dishes (35 mm; Costar, Cambridge, MA, USA; 2 × 10 6 cells dish
Construction of mammalian expression
) and transfected at 90-100% confluence using a modified calcium phosphate method with pAXD 5 and pAXD 2 or wild-type pAX vector (MOCK). Following transfection (4 h), CHO cells were shocked with 15% glycerol in PBS for 3 min, washed with PBS, and fed with fresh culture medium. After a recovery period (24 h), cells were trypsinized and replated in ␣-medium containing geneticin (G418) to isolate stable transformants. Selection of stably transformed cells was over a period of 4 weeks in the presence of 800 g ml −1 G418, after which time clonal cell lines were isolated by dilution cloning. ). Two days later, the culture medium was replaced by fresh ␣-medium containing IBMX for 30 min at 37°C and the cells were then incuMolecular Psychiatry bated with various drugs for 15 min. The reaction was terminated by adding 0.5 ml of stop solution and the intracellular cyclic AMP was then extracted and quantified using RIA (as described in Cell Cultures).
Results
Using a well characterized system of long-term monolayer cell cultures prepared from neonatal rat hypothalamic tissues as previously described, 22, 23 we have examined the effect of the endogenous ligand for both D 1 -like and D 2 -like receptors, dopamine, on the secretion of immunoreactive (ir) ANF from the culture. After four days of incubation with DA over a wide range of concentrations (10 −10 to 10 −5 M), ir-ANF levels in the conditioned medium showed biphasic changes (Figure 1a) . At low concentrations, in the range of 10 a D 2 -like receptor agonist. The findings suggest that under these circumstances, the overall suppression effect of DA is likely to be mediated through D 2 -like receptors. Consistent with this interpretation is the observation that the suppressive effect induced by low doses of DA (10 −9 to 10 −7 M) is abolished by concurrent incubation with sulpiride, a D 2 -like receptor antagonist (Figure 1b) . These results together suggest that the inhibitory effect of DA (the descending-phase) is mediated through the activation of D 2 -like receptors. In contrast to the marked suppression mediated by D 2 -like receptors, the lack of significant augmentation of ir-ANF release above the baseline level in the presence of sulpiride, suggests that DA-mediated D 1 -like receptor stimulating effect is, at best, modest. It is, however, important to point out that whereas the stimulating effect of a high concentration (10 −5 M) of DA, was blocked completely by SCH-23390, a specific D 2 -like receptor antagonist, it was also suppressed significantly (P Ͻ 0.05) but to a much lesser extent by sulpiride, the D 2 -like receptor antagonist (Figure 1b) . These To evaluate whether the biphasic effect induced by the interaction of D 1 -like and D 2 -like receptors may also affect the production of the peptide, Northern blot analysis 19, 20 was performed to examine the abundance of pro-ANF mRNA signals in the cultures that were treated with a protocol similar to that described in the secretion studies. The intensity of pro-ANF mRNA signal for each lane was standardized to that of the constituent housekeeping gene, GAPDH, after re-probing the membrane with GAPDH antisense oligonucleotides (Figure 2 ). Treatment with 10 −7 M of DA markedly reduced the abundance of pro-ANF mRNA to approximately 40% of the vehicle-treated controls whereas at a higher concentration of 10 −5 M, the amine doubled the level of pro-ANF mRNA expression (Figure 2a ). When applied alone, 10 −5 M of SKF-38393 significantly increased, whereas quinpirole treatment decreased the abundance of pro-ANF mRNA. In contrast, the enhanced pro-ANF mRNA expression by high dose of SKF-38393 (10 −5 M) was markedly potentiated by a concurrent application of a high dose of 10 −5 M of quinpirole in cultures. In all the above conditions, only a single band of signal for pro-ANF mRNA, similar in size to that of rat cardiac origin (not shown) was detected. Replacement of the antisense probes with sense oligonucleotides failed to show any hybridization signals for pro-ANF mRNA (data not shown).
Whereas we have localized D 1 and D 2 receptors in ANF-producing neurons in the past, 19, 20 our recent evidence suggests that D 5 receptors are also present in hypothalamic ANF neurons. 21 To address whether D 5 receptors may play a more important role than their D 1 receptor counterparts in functional modulation of hypothalamic ANF neurons, a specific antisense oligonucleotide complementary to D 5 receptors was synthesized and applied to our hypothalamic cultures to differentially suppress the expression of D 5 receptors. Figure 3 shows that the stimulatory but not the inhibitory effects of DA on ir-ANF release are abolished in cultures treated with antisense but not sense oligonucleotides for D 5 receptors.
To confirm that ANF neurons indeed possess both D 2 and D 5 receptors, we used a triple staining technique of in situ hybridization for both D 2 and D 5 receptor mRNA and immunostaining for ir-ANF. 20 Figure 4c M approximately 2 h before the supplement of dopamine. This protocol was repeated daily for 4 consecutive days over the period of the study and the media were collected for radioimmunoassay as described in Materials and Methods. Similar results were obtained when non-phosphorothioate-modified oligonucleotide antisense or sense was used in the study. Asterisks and hatches denote significant changes from the control group and from the cultures treated with similar levels of DA respectively. Values shown represent mean ± SEM, n = 3. *, #, P Ͻ 0.05; **, P Ͻ 0.01.
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To establish that the biphasic effect is indeed mediated through the interaction of D 5 and D 2 receptors, rat DA D 5 and human D 2 receptor cDNA have been cloned and co-transfected into CHO cells. 21, 34 Figure  5a shows that in these cells, SKF-38393 significantly elevates cAMP levels in a dose-related manner, whereas quinpirole produces an opposite effect by suppressing the level of cAMP. In addition, simultaneous activation of the two receptors with DA (Figure 5b ), or SKF-38393 in conjunction with quinpirole (Figure 5c ), induces biphasic changes in cAMP levels as seen in hypothalamic cell cultures treated in the same manner ( Figure 6 )
It is now evident that coupling of D 1 -like receptors to Gs, or D 2 -like receptors to Gi proteins, respectively, stimulates or inhibits the activity of adenylyl cyclases. [35] [36] [37] To confirm that this remains true in our culture system, Gs and Gi proteins were activated directly with various chemicals. Figure 7a shows that the biphasic change of ir-ANF release is reproduced when the D 1 -like receptor agonist is replaced with cholera toxin, a chemical that acts upon Gs proteins directly. 38 Similar results occur in studies where the D 2 receptor agonist is replaced with mastoparan (Figure 7b) , a peptide of wasp venom origin that produces a direct activation of Gi proteins. 39 These observations suggest that the biphasic interaction of D 5 and D 2 receptors is likely to be mediated through Gs and Gi proteins.
As the synergistic effect is also reproduced by replacing the D 1 -receptor agonist with forskolin that induces a direct pan-activation of all subtypes of adenylyl cyclases (shown in Figure 7a ), the possibility that the cyclases may play a central role in this biphasic effect needs to be considered. This notion is consistent with the finding that the D 2 agonist failed to potentiate the stimulating effect of Bu 2 cAMP, a synthetic analogue of cAMP or with IBMX, which raises intracellular cAMP level distal to the activation of adenylyl cyclases (Figure 7c) .
To examine the involvement of the type II isoform of adenylyl cyclase (ACII) in our studies, we constructed a 30-mer antisense oligonucleotide complementary to the second membrane-spanning domain of ACII and added it to our cultures to suppress the expression of ACII in ANF neurons. Figure 8 illustrates that this approach significantly inhibits the suppressing and augmenting effect of DA alone. Besides, it also abolishes the inhibiting and potentiating effect of quinpirole on SKF-38393-induced ir-ANF secretion.
In contrast, application of sense oligonucleotides under similar conditions failed to modulate the effects of these modalities (data not shown).
Discussion
In the present studies, we have exploited the paradigm of long-term primary cultures of rat hypothalamic cells 
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However, the concurrent action of dopamine on three subtypes of DA receptors in ANF neurons raises several interesting issues worthy of further discussion. First, in the absence of specific ligands, some of the D 1 -like receptor agonist mediated effects should have been attributed, at least in part, to D 5 receptors. Second, the possibility that under certain conditions, the biological action of one of the receptor subtypes may overshadow others also needs to be considered. The above argument is consistent with the notion that D 1 and D 5 receptor subtypes exhibit different biochemical characteristics 35, 40, 41 and their distributions in the brain differ substantially. [14] [15] [16] [17] In this context, it is noteworthy that by comparison, D 5 The above notion is further supported by findings from our transfection studies. In our CHO cells stably expressing D 5 and D 2 receptors, concurrent stimulation with their respective agonists or with dopamine produces a biphasic change of cAMP levels mimicking that seen in hypothalamic neuron cultures. This is in contrast to the earlier report that under similar conditions, an antagonistic but not synergistic action is seen in transfected CHO cells expressing D 1 and D 2 receptors concurrently when challenged with dopamine. 18 Taken together, the results strongly suggest that the biphasic effect found in our hypothalamic ANF neurons is primarily mediated through D 5 and D 2 receptors, and not D 1 and D 2 receptor interactions.
In our present studies, the hypothalamic cultures were stimulated daily for 4 consecutive days so that the abundance of ir-ANF release could be determined by our RIA in a reproducible and confident manner. Whereas DA-induced biphasic changes of ir-ANF release may be due to alterations in DA receptor abundance following repeated DA exposures, it appears unlikely for the following reasons. First, in vehicletreated control or drug-naïve cultures subjected to the same 4-day experimental protocol, our in-house findings showed that an acute 15-min stimulation with DA induced a biphasic pattern of cAMP changes similar to that found in cultures treated repeatedly with DA. Secondly, our unpublished observations show that in these drug-naïve cultures, 4-h exposure to a single DA treatment also induced biphasic changes of pro-ANF mRNA abundance mimicking that seen in repeated DA-stimulated cultures. Since changes of cAMP contents and pro-ANF mRNA abundance correlate well with the release of ir-ANF from our hypothalamic cultures, 22, 23 it is argued that in our present studies, alterations in the number and density of DA receptors do not contribute significantly to the biphasic responses of our hypothalamic cultures, including that of ir-ANF release. It is interesting to note that the antagonistic interaction of D 5 and D 2 receptors appears to take place when D 2 receptors are modestly activated by low concentrations of D 2 receptor agonist, an event known to induce a weak activation of Gi proteins. However, the synergistic interaction of the two receptors requires high concentrations of D 2 agonist. Under the latter condition, Gi proteins are expected to be activated strongly, and presumably this process would produce excess copies of ␤␥ subunits of Gi protein origin. The argument that the biphasic effect of D 5 and D 2 receptor interaction is mediated through Gs and Gi proteins is further substantiated by our studies conducted at postreceptor levels. For example, we have shown that a direct activation of the Gs and Gi proteins by cholera toxin and mastoparan in conjunction with D 2 and D 1 receptor agonists, respectively, induces the biphasic release of ir-ANF from our cultures. Furthermore, a similar biphasic effect is also detected when D 2 receptor agonist is used together with forskolin, a pan-adenylyl cyclase activator, but not with the cAMP analogue. All of the above discussion supports the argument that the biochemical events involved in the synergistic interaction are confined mainly to the level of G proteins and adenylyl cyclases but not beyond the step of cAMP generation.
The underlying mechanism of the subunits of G-protein interaction in our system remains unclear and further exploration is beyond the scope of the present studies. However, the synergism shows similarities to that reported in transfected tumor cell systems. In the latter, the type II isoform of adenylyl cyclase (ACII) is synergistically activated by high levels of ␤␥ subunits in the presence of Gs␣, 42, 43 both of them have been cotransfected into the tumor cells of interest. Relevant to this point is the fact that ACII is expressed abundantly in the rat hypothalamus. [44] [45] [46] The proposition that the synergistic effect of co-activation of D 5 receptor (coupling to Gs-protein) and D 2 receptor (coupling to Gi) on hypothalamic ANF neurons may involve a similar mechanism therefore needs to be considered. The present findings of the blocking effect of ACII antisense on the biphasic response induced by dopamine and its agonists strongly suggest that both the antagonistic and synergistic effect of D 5 and D 2 receptor interaction are mediated, at least in part, through the modulation of the activity of ACII.
Our present results add a new dimension to the knowledge of D 5 and D 2 receptor interaction in DAresponsive neurons of the central nervous system. They have further substantiated the general principle of synergistic interaction of Gs␣ and ␤␥ subunits of Gi proteins of an adenylyl cyclase isoform mediated through dopamine receptor subtypes and its neurophysiological relevance. However, it is also important to point out that our findings have extended the interaction to include that of an antagonism which takes place in the presence of a low or modest availability of the subunits of Gi proteins. Whereas the physiological significance of D 5 and D 2 interaction requires further elucidation, in general, our present findings suggest that at low levels, DA may behave as an inhibitor to these neurons, whilst high availability of the neurotransmitter augments the function of the neurons.
Functional aberrations in DA-producing or DAsensitive neurons of the central nervous system have been strongly implicated in mental illnesses such as schizophrenia, as many of these patients respond favorably to typical or atypical anti-psychotic drugs. 3, 4 Of interest is the fact that the therapeutic efficacy of all of these drugs appears to act by interfering with binding of DA to D 2 or D 5 /D 1 receptors in critical regions of the central nervous system. [5] [6] [7] Thus, although the full complexity of the regulation of ANF neurons by DA involving D 5 and D 2 receptor interaction requires more investigation, it has considerable implications for explaining the neurobiochemical aberrations which affect neurons in other critical regions of the central nervous system and which underlie various mental illnesses.
